High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer. [electronic resource]
Producer: 20170724Description: 248-54 p. digitalISSN:- 1537-453X
- Angiopoietin-1 -- blood
- Angiopoietin-2 -- blood
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Becaplermin
- Bevacizumab -- administration & dosage
- Biomarkers, Tumor -- blood
- Breast Neoplasms -- chemistry
- Carcinoma, Ductal, Breast -- chemistry
- Chemotherapy, Adjuvant
- Cyclophosphamide -- administration & dosage
- Docetaxel
- Doxorubicin -- administration & dosage
- Female
- Fibroblast Growth Factor 2 -- blood
- Humans
- Interleukin-1alpha -- blood
- Matrix Metalloproteinase 9 -- blood
- Neoadjuvant Therapy
- Neovascularization, Pathologic -- drug therapy
- Platelet Endothelial Cell Adhesion Molecule-1 -- blood
- Platelet-Derived Growth Factor -- metabolism
- Prospective Studies
- Proto-Oncogene Proteins c-sis -- blood
- Receptor, ErbB-2 -- analysis
- Receptor, TIE-2 -- blood
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Taxoids -- administration & dosage
- Vascular Endothelial Growth Factor A -- blood
- Vascular Endothelial Growth Factor Receptor-2 -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.